Patient and public involvement in the benefit-risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
患者和公众参与健康产品的获益风险评估和决策：法国国家药品和健康产品安全局 (ANSM) 科学顾问委员会的立场
期刊:Bmj Global Health
影响因子:6.1
doi:10.1136/bmjgh-2023-011966
Belgodère, Laëtitia; Pougheon Bertrand, Dominique; Jaulent, Marie Christine; Rabeharisoa, Vololona; Janssens, Walter; Rollason, Victoria; Barbot, Janine; Vernant, Jean Paul; Oualikene Gonin, Wahiba; Maison, Patrick; Ankri, Joel
